Acusense

翔安生醫

AIoT, AI medical training, Long-term care, Home care, and Telemedicine

Through Artificial Intelligence (AI), Internet of Things (IoT) and System Integration (SI)

Protecting medical professionals and improving patient safety

Through artificial intelligence (AI), Internet of Things (IoT) and system integration (SI)

Protecting medical professionals and improving patient safety

Acusense Biomedical Technology Co., Ltd. focuses on 3 core technologies: Artificial Intelligence (AI), medical Internet of Things (IoT) and System Integration (SI). We are committed to combining technology and medicine to improve the quality and efficiency of care. We not only continue to make breakthroughs in technology, but also promote next-generation medicine with comprehensive design services.

Read more

Self-developed products

Re-Minder

Intelligent Hemostasis Alarm

Suitable for nursing or home care and serves as a reminder for users to remove the tourniquet after stopping bleeding from an injection, blood draw, or dialysis.

Read more
Re-Minder 智能止血警示器

ROCKBOX

Smart Integrated Gateway

The applicable areas include remote health management care, long-term care wards, remote care for the elderly, rehabilitation wards, and other settings involving patients who require remote continuous care.

Read more
ROCKBOX雙模閘道器

IDH-AI Prediction System 

AI early warning system for hypotension during dialysis

When a patient is predicted to be at risk, a warning window and sound alert will pop up to allow caregivers to adjust dialysis parameters and resolve possible hypotension issues.

Read more
透析中低血壓預警模型系統

Technical System Features

 Acusense focuses on smart healthcare and telehealth, by combining AIoT, product development, regulatory compliance, AI/ML, wireless connectivity and other technologies.

We specialize in product compliance and medical data integration to provide long-term care and telemedicine solutions.

product development

Acusense Product Development

We focus on the research and development of independent medical products, utilizing smart gateways and AI technology to achieve real-time monitoring and early warning of physiological data, helping medical institutions optimize their care processes. By integrating data science, we provide high-value information to help managers make accurate decisions and promote the development of next-generation smart healthcare.

Engineering services

Acusense Engineering Services

We provide customized engineering service solutions, support research projects, medical regulatory certification, and offer OEM/JDM services. Through our expertise and experience, we participate in customer product development and help accelerate product launch.

無縫循環跑馬燈
TECHNICAL SYSTEM



Partners

Nordic, Microsoft, Nvidia, Google, Cathay Financial Holdings, Chunghwa Telecom, HealthLink, DaAi Long-term Care, Lingqun Computer, Taichung Ministry of Health and Welfare Hospital, Annan Hospital, Kaohsiung Veterans General Hospital, Taichung Veterans General Hospital, Yuncheng, Taibo Technology, Noyak, Tseung Kwan O Hospital, Mackay Memorial Hospital, Tatung Hospital, Xihua Crystal



Latest News


By Acusense August 20, 2024
Acusense recently participated in the "Home-Based Healthcare Technology Empowerment" event, co-hosted by the Institute for Information Industry (III) and National Cheng Kung University. Held at the Grand Hi-Lai Hotel, the event brought together medical experts, technology developers, and policymakers from across the country to explore the latest developments and future trends in telemedicine and home healthcare technologies.
By Acusense June 15, 2023
As one of the most prestigious and influential academic events in nephrology, the ERA Congress showcased cutting-edge developments in both basic and clinical research, alternative therapies, transplantation technologies, and advances in diabetic nephropathy and internal medicine. At the event, Acusense presented its latest innovation in hemodialysis safety—a proprietary venous needle dislodgement and bleeding alert system. This breakthrough technology represents a major step forward in enhancing the safety and effectiveness of dialysis treatment, demonstrating Acusense’s ongoing commitment to improving patient care and clinical outcomes. The innovation was met with strong interest and positive feedback from attending experts.
By Acusense April 6, 2023
Acusense began its entry into the European market starting with the Czech Republic in Central and Eastern Europe, marking a new chapter in its international expansion. In April 2023, Acusense was successfully selected to participate in the Caelestinus Accelerator Program in the Czech Republic, representing a significant step toward entering the European market.